Test formulation + Reference formulation
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
Jan 19, 2019 → Apr 2, 2020
NCT ID
NCT03792477About Test formulation + Reference formulation
Test formulation + Reference formulation is a phase 1 stage product being developed by Pfizer for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT03792477. Target conditions include Hypogonadism.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03792477 | Phase 1 | Completed |
Competing Products
20 competing products in Hypogonadism